Sponsor
Korea University Guro Hospital
Clinical research sponsor
Clinical trials
44 shownQuantitative Chest CT and Multi-Omics to Distinguish Asthma From COPD and Predict Treatment ResponseNCT07602192 · lead sponsor · 2025-12-22
RECRUITINGComparison of Clinical Efficacy Between Letrozole + Ribociclib and Fulvestrant + Letrozole + Ribociclib in Hormone Receptor Positive, HER2 Negative Metastatic Breast CancerNCT05816655 · lead sponsor · 2023-05-31
RECRUITINGAI-Driven Precision Diagnostic System for Lung Cancer Based on Liquid BiopsyNCT07009769 · lead sponsor · 2024-10-16
COMPLETEDSP Robotic Versus VATS Anatomical Pulmonary Resection for Patients With NSCLCNCT06202690 · lead sponsor · 2024-01-09
NOT_YET_RECRUITINGImpact of Maxigesic on Delirium After Minimally Invasive Lung Surgery in Elderly PatientsNCT05834569 · lead sponsor · 2023-06-15
TERMINATEDComparision of Various Biomarkers Between Peripheral and Pulmonary BloodNCT05587114 · lead sponsor · 2022-10-13
UNKNOWNAlleviating Stress by Mobile Application' for DepressionNCT05312203 · lead sponsor · 2022-05-15
UNKNOWNHome BIA Management System in Patients With Heart FailureNCT05177081 · lead sponsor · 2021-08-23
UNKNOWNThe Evaluation of Laser Lancing Devices in Adult Type 2 Diabetes PatientsNCT05251506 · lead sponsor · 2021-08-10
UNKNOWNImmunogenicity After Revaccination With 23-valent Pneumococcal Polysaccharide Vaccine: Healthy Elderly People Versus Diabetic PatientsNCT04875858 · lead sponsor · 2021-05-01
UNKNOWNEffects of APIXaban on BRAIN Protection in Patients With Sinus Rhythm and Heart Failure: APIXBRAIN-HF TrialNCT04696120 · lead sponsor · 2021-03-02
UNKNOWNSLN Detection With Tc-MSA-ICG in Lung Cancer PatientsNCT05039905 · lead sponsor · 2021-02-15
UNKNOWNOncometabolic SurgeryNCT07437573 · lead sponsor · 2020-07-07
COMPLETEDMulticenter Clinical Research for Early Diagnosis of Lung Cancer Using Blood Plasma Derived ExosomeNCT04529915 · lead sponsor · 2020-04-09
UNKNOWNIdentification of Integrin ab Expression in Lung Cancer PatientsNCT06167941 · lead sponsor · 2019-12-19
COMPLETEDRetreatment With Epidermal Growth Factor Receptor(EGFR) Tyrosine Kinase Inhibitor in EGFR Mutation Positive PatientsNCT03382795 · lead sponsor · 2018-01-03
UNKNOWNSubcostal Single-port Versus Intercostal Multi-port Robotic Lobectomy for Non-small Cell Lung CancerNCT07099105 · lead sponsor · 2017-01-01
COMPLETEDManidipine Versus Amlodipine in Patients With HypertensionNCT03106597 · lead sponsor · 2015-08-20
TERMINATEDImmunogenicity and Safety of 13-valent Pneumococcal Conjugate Vaccine Among HIV-infected AdultsNCT03838497 · lead sponsor · 2015-04-02
COMPLETEDConventional Vaccine and Intradermal Vaccine Among HIV-infected Young SubjectsNCT02398097 · lead sponsor · 2011-11-01
COMPLETEDAn Adherence Study of Antipsychotic Medication in Outpatients With Schizophrenia or Schizoaffective DisorderNCT00861003 · lead sponsor · 2009-04-01
UNKNOWNProgression to Impaired Glucose Tolerance and Type 2 Diabetes in the Korean People-based KNDP StudyNCT01034826 · lead sponsor · 2007-02-01
COMPLETEDEfficacy and Safety of Lacidipine and Amlodipine on Blood Pressure in Korean ISH Patients Aged 60 to 80 YearsNCT00460915 · lead sponsor · 2007-01-01
COMPLETEDAnesthesia and Non-small Cell Lung Cancer RecurrenceNCT06330038 · collaborator · 2024-08-05
RECRUITINGSurgical TreAtment for Obesity Related Disease and Onco-Metabolic SurgeryNCT04284943 · collaborator · 2020-12-01
RECRUITINGA Study to Assess the Efficacy and Safety of Vutiglabridin in Early Parkinson's Disease PatientsNCT06329141 · collaborator · 2024-07-22
COMPLETEDEfficacy of the Mobile Application for Prediction and Prevention of Mood Episode Recurrence Based on Machine LearningNCT05400785 · collaborator · 2022-05-27
COMPLETEDComparing Safety and Efficacy of Amlodipine Verses S Amlodipine in Patients With Essential HypertensionNCT04554303 · collaborator · 2020-10-28
UNKNOWNEffect of Alogliptin/Pioglitazone on the Preservation of Long-term Beta-cell FunctionNCT02823808 · collaborator · 2017-07-01
UNKNOWNHospital-based Diabetes Prevention Study in KoreaNCT02981121 · collaborator · 2016-11-01
UNKNOWNLong-term Outcomes of Chronic Hepatitis C Patients Post Sofosbuvir-based TreatmentNCT03042520 · collaborator · 2016-08-01
UNKNOWNEffect of Short-term Motilitone Therapy on Health-related Quality of Life in PD Patients With Gastrointestinal SymptomsNCT02775591 · collaborator · 2016-04-01
COMPLETEDEfficacy and Safety of Adjuvant Pemetrexed Plus Cisplatin for Adenocarcinoma of LungNCT02498860 · collaborator · 2015-09-01
COMPLETEDFimasartan/Amlodipine Combination Phase IIINCT02152306 · collaborator · 2014-04-01
COMPLETEDStudy of Anti-Viral Prophylaxis for HBsAg(+) or HBcAb(+)/HBsAb(-) Patients Starting Anti-TNFαNCT01694264 · collaborator · 2012-09-01
TERMINATEDA Randomized, Double-Blind, Placebo-Controlled, 3x3 Factorial Design, Phase II Study to Evaluate the Antihypertensive Efficacy and Safety of Combination of Fimasartan and Amlodipine in Patients With Essential HypertensionNCT01518998 · collaborator · 2011-08-01
COMPLETEDFulvestrant (F)/Goserelin (G) vs Anastrozole (A)/G vs G for Premenopausal WomenNCT01266213 · collaborator · 2010-12-01
UNKNOWNA Clinical Study to Evaluate Efficacy and Safety of Fimasartan/Hydrochlorothiazide Combination-therapyNCT01258673 · collaborator · 2010-11-01
COMPLETEDAsthma Control in Elderly Patients With MontelukastNCT01147510 · collaborator · 2010-07-01
COMPLETEDStudy of the Durability of Glycemic Control With NateglinideNCT00858013 · collaborator · 2009-04-24
COMPLETEDCilostazol Versus Aspirin for Primary Prevention of Atherosclerotic EventsNCT00886574 · collaborator · 2009-04-01
UNKNOWNClinical Study to Evaluate the Antihypertensive Efficacy and Safety of Fimasartan in Hypertension PatientsNCT00922480 · collaborator · 2008-12-01
COMPLETEDStudy To Evaluate Beta Cell Function and Glycemic Outcome by Intensive Insulin TherapyNCT00474838 · collaborator · 2007-04-01
COMPLETEDKorea National Diabetes ProgramNCT01212198 · collaborator · 2005-05-01
UNKNOWNSponsor roles
lead sponsor23
collaborator21
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.